About Us

Leadership Team and Board of Directors

Our dedicated Leadership Team is committed to leveraging their extensive expertise and experience in drug discovery and development to bring innovative therapies to patients with glioblastoma and other brain tumors. Team members have developed over a billion dollars in new companies, including other drugs that are currently approved for the treatment of cancer.

Mark C. Rogers, MD; MBA

Founder and Executive Chair

Board Member

Randall B.
Riggs

President and Chief Executive Officer

Board Member

Theodore C Solomon

Founder and Chief Financial Officer

Board Member

Elizabeth London Rogers, MD

Founder and Chief Operations Officer

Board Member

Clifford T. Solomon, MD

Clinical Professor UM Neurosurgery

Founder and Chief Medical Officer

Board Member

Mark S. Cushman, PhD., PharmD

Distinguished Professor of Medicinal Chemistry at Purdue University

Chief Scientific Officer

Board Member

Mark D. Baganz, MD

Independent Director

Board Member